We are live on ! Find out more
WA

Wambolt & Associates Portfolio holdings

AUM $297M
1-Year Est. Return 17.23%
This Fund
S&P 500
This Quarter Est. Return
-1.98%
1 Year Est. Return
+17.23%
3 Year Est. Return
+62.24%
5 Year Est. Return
+110.77%
10 Year Est. Return
AUM
$276M
AUM Growth
-$5.47M
Cap. Flow
+$4.06M
Cap. Flow %
1.47%
Top 10 Hldgs %
18.74%
Holding
259
New
9
Increased
120
Reduced
102
Closed
18

Top Buys

Rank Stock Value
1
PB icon
Prosperity Bancshares
PB
+$4.66M
2
AAPL icon
Apple
AAPL
+$1.64M
3
COST icon
Costco
COST
+$982K
4
INTU icon
Intuit
INTU
+$936K
5
CBOE icon
Cboe Global Markets
CBOE
+$799K

Sector Composition

Rank Sector Weight
1 Technology 16.66%
2 Financials 16.57%
3 Consumer Staples 9.3%
4 Industrials 8.1%
5 Healthcare 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGX icon
76
Quest Diagnostics
DGX
$26B
$1.25M 0.45%
10,361
+637
+7% +$84.9K
STLD icon
77
Steel Dynamics
STLD
$39B
$1.21M 0.44%
11,418
+1,969
+21% +$205K
HD icon
78
Home Depot
HD
$351B
$1.19M 0.43%
3,972
+498
+14% +$160K
CRM icon
79
Salesforce
CRM
$159B
$1.15M 0.42%
901,248
+4
+0% +$864
SLYV icon
80
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.06B
$1.15M 0.42%
16,165
-264
-2% -$20.4K
EFG icon
81
iShares MSCI EAFE Growth ETF
EFG
$17.1B
$1.14M 0.41%
13,381
-1,023
-7% -$94.3K
PGR icon
82
Progressive
PGR
$124B
$1.14M 0.41%
8,189
+1,573
+24% +$207K
MFC icon
83
Manulife Financial
MFC
$73.5B
$1.13M 0.41%
63,172
+13,198
+26% +$249K
TMO icon
84
Thermo Fisher Scientific
TMO
$212B
$1.13M 0.41%
2,277
+54
+2% +$28.8K
FM
85
DELISTED
iShares Frontier and Select EM ETF
FM
$1.13M 0.41%
43,511
+527
+1% +$14.2K
BR icon
86
Broadridge
BR
$19.1B
$1.12M 0.41%
6,347
-441
-6% -$78.1K
XOM icon
87
ExxonMobil
XOM
$632B
$1.12M 0.4%
9,644
+3,527
+58% +$387K
VBR icon
88
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.2B
$1.08M 0.39%
6,909
+253
+4% +$42.3K
SLF icon
89
Sun Life Financial
SLF
$45.2B
$1.08M 0.39%
22,482
-1,634
-7% -$81.9K
VZ icon
90
Verizon
VZ
$188B
$1.07M 0.39%
33,607
-74
-0.2% -$2.5K
PGX icon
91
Invesco Preferred ETF
PGX
$3.81B
$1.06M 0.39%
98,519
-23,584
-19% -$264K
VOE icon
92
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.1B
$1.04M 0.38%
8,080
+344
+4% +$47.6K
SPLV icon
93
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
$1.04M 0.38%
17,902
-5,071
-22% -$313K
BBY icon
94
Best Buy
BBY
$17.8B
$1.02M 0.37%
14,715
-1,693
-10% -$131K
NTR icon
95
Nutrien
NTR
$32.1B
$1.01M 0.37%
16,800
+2,396
+17% +$152K
RTX icon
96
RTX Corp
RTX
$297B
$1M 0.36%
14,075
-392
-3% -$33.6K
SHEL icon
97
Shell
SHEL
$246B
$999K 0.36%
15,769
+1,936
+14% +$121K
ICF icon
98
iShares Select U.S. REIT ETF
ICF
$2.08B
$983K 0.36%
19,955
-72
-0.4% -$3.94K
BKNG icon
99
Booking.com
BKNG
$160B
$981K 0.36%
7,925
+375
+5% +$45.4K
CDNS icon
100
Cadence Design Systems
CDNS
$93.7B
$980K 0.36%
4,142
+1,911
+86% +$447K

Similar funds

Wambolt & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Wambolt & Associates held 259 positions worth $276M, down 1.9% from $281M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Wambolt & Associates's Q3 2023 filing shows 9 new, 120 increased, 102 reduced and 18 closed positions. Its largest new stake was Cboe Global Markets: 5,429 shares worth $851K. The largest sale was iShares 0-5 Year High Yield Corporate Bond ETF, an estimated $2.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Staples.

  • Wambolt & Associates's largest Q3 2023 buy was Cboe Global Markets: 5,429 shares worth $851K.
  • Wambolt & Associates added most to Prosperity Bancshares in Q3 2023, an estimated $4.66M increase.
  • Wambolt & Associates's biggest Q3 2023 reduction was iShares 0-5 Year High Yield Corporate Bond ETF, cutting an estimated $2.7M.
  • Wambolt & Associates fully exited Dollar General in Q3 2023, selling an estimated $1.99M.
  • Wambolt & Associates's ten largest holdings make up 19% of its $276M portfolio in Q3 2023.
  • Wambolt & Associates opened 9 new positions and closed 18 in Q3 2023.
  • Wambolt & Associates's portfolio value fell 1.9% quarter-over-quarter to $276M.

Based on Wambolt & Associates's 13F filing for Q3 2023, filed 7 Nov 2023.